Broelsch C E, Emond J C, Thistlethwaite J R, Rouch D A, Whitington P F, Lichtor J L
Department of Surgery, University of Chicago, Illinois 60637.
Transplantation. 1988 Mar;45(3):519-24. doi: 10.1097/00007890-198803000-00003.
Orthotopic liver transplantation (OLT) of the pediatric patient is often limited by the availability of a size-matched donor organ. Use of reduced liver transplantation (RLT) can increase the proportion of candidates transplanted and may reduce overall mortality. We report herein the initial clinical application of RLT in the United States. Indications for RLT included fulminant hepatic failure (n = 2), acute hepatic artery thrombosis (n = 3), and chronic liver disease unresponsive to inpatient support and more than 30 days on transplant list (n = 4). Donor hepatectomy was performed using standard techniques. Formal hepatic resection was performed ex-vivo to create a size-matched graft, from the larger donor organ, which was implanted in the orthotopic position. Between 11/84 and 4/87, 70 pediatric patients were evaluated for OLT, and 33 of these were transplanted. During this period only 5 patients (7%) died awaiting OLT. Of 33 patients treated at the University of Chicago, 5 received RLT. Donor: recipient weight ratios ranged from 2:1 to 8.1:1. For RLT median operative blood loss was 1.7 blood volumes (range 0.5-11.7) with an operative time of 9.3 + 3.5 hr. Acceptable early graft function was observed in five patients, all of whom were discharged from the hospital. Four of these five patients are alive between 2 and 48 months after transplantation. Marginal graft function with cholestasis and coagulopathy was associated with acute intracranial hemorrhage and neurologic death in one case. One patient died intraoperatively with non-function caused by the use of a liver from a donor with steatosis and a poor size match. Another patient died on day 5 with primary nonfunction and persistent hemorrhage. Systemic cytomegalovirus infection was the cause of death in the other two cases. RLT can provide life-sustaining liver function in urgent clinical settings. The graft can serve as a temporary or permanent liver replacement. With evolution of the technique RLT could eventually be offered to more elective candidates and increase the utilization of available donors by reducing size limitations in OLT.
小儿患者的原位肝移植(OLT)常常受到大小匹配的供体器官可用性的限制。采用减体积肝移植(RLT)可增加接受移植的候选者比例,并可能降低总体死亡率。我们在此报告RLT在美国的首次临床应用。RLT的适应证包括暴发性肝衰竭(n = 2)、急性肝动脉血栓形成(n = 3)以及对住院治疗无反应且在移植等待名单上超过30天的慢性肝病(n = 4)。供体肝切除术采用标准技术进行。在体外进行正规肝切除,从较大的供体器官上切取大小匹配的移植物,然后将其植入原位。在1984年11月至1987年4月期间,70例小儿患者接受了OLT评估,其中33例接受了移植。在此期间,仅有5例患者(7%)在等待OLT过程中死亡。在芝加哥大学接受治疗的33例患者中,5例接受了RLT。供体与受体的体重比范围为2:1至8.1:1。对于RLT,术中中位失血量为1.7个血容量(范围为0.5 - 11.7),手术时间为9.3 ± 3.5小时。5例患者观察到早期移植物功能良好,所有患者均出院。这5例患者中有4例在移植后2至48个月存活。1例患者出现伴有胆汁淤积和凝血障碍的边缘性移植物功能,并伴有急性颅内出血和神经源性死亡。1例患者术中因使用脂肪变性且大小匹配不佳的供体肝脏导致移植物无功能而死亡。另1例患者在术后第5天因原发性移植物无功能和持续出血死亡。另外2例患者死于全身性巨细胞病毒感染。RLT可在紧急临床情况下提供维持生命的肝功能。该移植物可作为临时或永久性的肝脏替代物。随着技术的发展,RLT最终可能会应用于更多择期候选者,并通过减少OLT中的大小限制来提高可用供体的利用率。